By Benjamin Chiou
Date: Thursday 24 Sep 2026
(Sharecast News) - The largest market purchase of shares in London on Thursday came from Oxford Biomedica's chair Roch Doliveux. who upped his stake in the cell and gene therapy company after a sharp drop in the stock over the year to date.
| PDMR Dealing | 24-Sep-2026 | 13:58 | RNS |
| Holding(s) in Company | 22-Sep-2026 | 07:00 | RNS |
| Interim Results | 22-Sep-2026 | 07:00 | RNS |
| Holding(s) in Company | 21-Sep-2026 | 10:43 | RNS |
| Holding(s) in Company | 21-Sep-2026 | 10:38 | RNS |
| Should you buy shares in Oxford Biomedica? | 29-Jul-2026 | Times |
| Need to know: Opec cuts forecast ... Tesco cuts ... | 16-Aug-2008 | Times |
| Need to know | 10-May-2008 | Times |
| DSG International may be losing its spark | 12-Feb-2008 | Telegraph |
| Oxford BioMedica clinches $690m licensing deal f... | 29-Mar-2007 | The Independent |
No recent information was found.
| Currency | UK Pounds |
| Share Price | 490.00p |
| Change Today | 9.00p |
| % Change | 1.87 % |
| 52 Week High | 913.00p |
| 52 Week Low | 424.00p |
| Volume | 605,319 |
| Shares Issued | 121.05m |
| Market Cap | £593.14m |
| Beta | 0.03 |
| RiskGrade | 125 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 3 |
| Buy | 1 |
| Neutral | 4 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 8 |

| No dividends found |
| Time | Volume / Share Price |
| 16:35 | 167,835 @ 490.00p |
| 16:35 | 288 @ 490.00p |
| 16:35 | 1,610 @ 490.00p |
| 16:35 | 149 @ 490.00p |
| 16:35 | 835 @ 490.00p |
| Chair | Roch Doliveux |
| CEO | Frank Mathias |
| CFO | Lucinda (Lucy) Crabtree |
You are here: research